What is the current market valuation of the US parotid tumors market?

The market valuation was $333.9 Million in 2024. Read More

What is the projected market size for the US parotid tumors market by 2035?

The projected market size is $523.34 Million by 2035. Read More

What is the expected CAGR for the US parotid tumors market during the forecast period 2025 - 2035?

The expected CAGR is 4.17% during the forecast period. Read More

Which companies are the key players in the US parotid tumors market?

Key players include Johnson & Johnson, Stryker Corporation, Medtronic, Boston Scientific, Siemens Healthineers, GE Healthcare, Philips Healthcare, and Varian Medical Systems. Read More

What are the market segments based on the type of tumor?

The segments include Benign Tumors valued at $150.0 - $230.0 Million, Malignant Tumors at $120.0 - $180.0 Million, and Metastatic Tumors at $63.9 - $113.34 Million. Read More

What treatment methods are included in the US parotid tumors market?

Treatment methods include Surgery valued at $133.17 - $205.0 Million, Radiation Therapy at $83.34 - $130.0 Million, Chemotherapy at $66.67 - $100.0 Million, and Targeted Therapy at $50.0 - $88.34 Million. Read More

What diagnostic methods are utilized in the US parotid tumors market?

Diagnostic methods include Imaging Tests valued at $100.0 - $160.0 Million, Biopsy at $120.0 - $180.0 Million, and Physical Exam at $113.9 - $183.34 Million. Read More

How does the patient demographic segment break down in the US parotid tumors market?

The patient demographics include Adults valued at $200.0 - $320.0 Million, Children at $80.0 - $120.0 Million, and Geriatric Patients at $53.9 - $83.34 Million. Read More

What trends are influencing the growth of the US parotid tumors market?

Trends include advancements in treatment technologies and increasing awareness of parotid tumors, contributing to market growth. Read More

What factors could impact the future growth of the US parotid tumors market?

Factors may include regulatory changes, technological advancements, and shifts in patient demographics. Read More

US Parotid Tumors Market

ID: MRFR/Pharma/18457-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

US Parotid Tumors Market Research Report By Type of Tumor (Benign Tumors, Malignant Tumors, Metastatic Tumors), By Treatment Method (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy), By Diagnosis Method (Imaging Tests, Biopsy, Physical Exam) and By Patient Demographics (Adults, Children, Geriatric Patients) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Food, Beverages & Nutrition, BY Type of Tumor (USD Million)
  1. 4.1.1 Benign Tumors
  2. 4.1.2 Malignant Tumors
  3. 4.1.3 Metastatic Tumors
2. 4.2 Food, Beverages & Nutrition, BY Treatment Method (USD Million)
  1. 4.2.1 Surgery
  2. 4.2.2 Radiation Therapy
  3. 4.2.3 Chemotherapy
  4. 4.2.4 Targeted Therapy
3. 4.3 Food, Beverages & Nutrition, BY Diagnosis Method (USD Million)
  1. 4.3.1 Imaging Tests
  2. 4.3.2 Biopsy
  3. 4.3.3 Physical Exam
4. 4.4 Food, Beverages & Nutrition, BY Patient Demographics (USD Million)
  1. 4.4.1 Adults
  2. 4.4.2 Children
  3. 4.4.3 Geriatric Patients
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Johnson & Johnson (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Stryker Corporation (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Medtronic (IE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Boston Scientific (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Siemens Healthineers (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 GE Healthcare (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Philips Healthcare (NL)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Varian Medical Systems (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE OF TUMOR
3. 6.3 US MARKET ANALYSIS BY TREATMENT METHOD
4. 6.4 US MARKET ANALYSIS BY DIAGNOSIS METHOD
5. 6.5 US MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
6. 6.6 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
9. 6.9 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
11. 6.11 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
12. 6.12 FOOD, BEVERAGES & NUTRITION, BY TYPE OF TUMOR, 2024 (% SHARE)
13. 6.13 FOOD, BEVERAGES & NUTRITION, BY TYPE OF TUMOR, 2024 TO 2035 (USD Million)
14. 6.14 FOOD, BEVERAGES & NUTRITION, BY TREATMENT METHOD, 2024 (% SHARE)
15. 6.15 FOOD, BEVERAGES & NUTRITION, BY TREATMENT METHOD, 2024 TO 2035 (USD Million)
16. 6.16 FOOD, BEVERAGES & NUTRITION, BY DIAGNOSIS METHOD, 2024 (% SHARE)
17. 6.17 FOOD, BEVERAGES & NUTRITION, BY DIAGNOSIS METHOD, 2024 TO 2035 (USD Million)
18. 6.18 FOOD, BEVERAGES & NUTRITION, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
19. 6.19 FOOD, BEVERAGES & NUTRITION, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE OF TUMOR, 2025-2035 (USD Million)
  2. 7.2.2 BY TREATMENT METHOD, 2025-2035 (USD Million)
  3. 7.2.3 BY DIAGNOSIS METHOD, 2025-2035 (USD Million)
  4. 7.2.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Type of Tumor (USD Million, 2025-2035)

Benign Tumors
Malignant Tumors
Metastatic Tumors

Food, Beverages & Nutrition By Treatment Method (USD Million, 2025-2035)

Surgery
Radiation Therapy
Chemotherapy
Targeted Therapy

Food, Beverages & Nutrition By Diagnosis Method (USD Million, 2025-2035)

Imaging Tests
Biopsy
Physical Exam

Food, Beverages & Nutrition By Patient Demographics (USD Million, 2025-2035)

Adults
Children
Geriatric Patients

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”